Conferences - Seminars

24OCT
Thumbnail
  12:15-13:15 SV 1717

Parkinson’s disease (PD) is the most common movement disorder characterized by the progressive loss of dopaminergic cells in the substantia nigra pars compacta. Accumulating evidence indicates that the interactions between genetic and environmental factors cause PD. Although several monogenic mutations linked to rare familial PD have been identified, other genetic determinants causative for sporadic PD, ... Read more about "BMI SEMINAR // Transcriptional regulation of survival of dopaminergic neurons and its implication in Parkinson’s disease"
By Emi Nagoshi, Behavioral neuroscience & neurodegeneration, Dept. Of Genetics and ...
31OCT
Thumbnail
  12:15-13:15 SV 1717

Apathy is a common and debilitating negative symptom of schizophrenia and other neuropsychiatric disorders. While originally defined as an impairment of motivation, apathy has recently been defined as a quantitative reduction of goal-directed behavior. Treatment options for apathy remain very limited, in particular for patients with schizophrenia. In this talk I will present a research ... Read more about "BMI Seminar // Apathy in patients with schizophrenia - an impairment of goal-directed behavior"
By Stefan Kaiser, Clinical and Experimental Psychopathology, Dept. Of Psychiatry, University ...
14NOV
Cancelled Thumbnail
  12:15-13:15 SV1717

The BMI-Kaloy Prize Award is given in recognition of an exceptional work in neuroscience, biology, physics, or psychology, which confirms, refutes or elucidates a theory of epistemology or the philosophy of mind. The amount of the BMI‐Kaloy Prize is US$ 10,000 Deadline for application -more info coming soon Information for Applicants Applications should consist of: ... Read more about "The BMI-Kaloy Prize 20"
By BMI-Kaloy Prize Awarardee
14NOV
Thumbnail
  12:15-13:15 SV 1717

It has long been suggested that failure appropriately to inhibit impulses stems from a deficit in prefrontal cortical inhibitory function. Here it will be suggested that impulsivity, which predicts the vulnerability to develop addiction to stimulant drugs as well as compulsive behaviours as observed in Obsessive Compulsive Disorder and early onset Parkinson’s Disease, also stems ... Read more about "BMI SEMINAR // Impulse control: from the urge to its inhibition, a transnological approach to the vulnerability to compulsive disorders"
By David Belin, Behavioural and Clinical Neuroscience Institute, Department of Psychology ...
09JAN
Thumbnail
By Alejandro Ocampo, Department of Pharmacology and Toxicology, Faculty of Biology ...
16JAN
Thumbnail
  12:15-13:15 SV 1717

Huntington's disease (HD), the most common dominantly inherited neurodegenerative disorder is characterized by a progressive striatal and cortical neurodegeneration associated with cognitive and behavioral disturbance. So far, many are the aberrant molecular mechanisms described to be associated with the disease, however much remains to be defined. In the last decade, perturbed metabolism of gangliosides, glycosphingolipids ... Read more about "BMI SEMINAR // Sphingolipid metabolism: new perspectives for treating Huntington's disease"
By Vittorio Maglione, Centre for Neurogenetics and Rare Diseases, IRCCS Neuromed ...
23JAN
Thumbnail
By Matthew Hill, Hotchkiss Brain Institute, he Mathison Center, for Mental ...
20FEB
Thumbnail
By  Marlene Bartos, Cellular and Systemic Neuroscience, Institute for Physiology I ...
06MAR
Thumbnail
By Takeshi Sakaba, Laboratory of Molecular Synaptic Function, Graduate School of ...
13MAR
Thumbnail
By Julia Lemos, Department of Neuroscience, The University of Minnesota, Minneapolis ...
27MAR
Thumbnail
By Carlos Ribeiro, Behavior and Metabolism Lab, Champalimaud Research, Champalimaud Centre ...